Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferulic acid + angelica archangelica extract is a **dietary supplement** consisting of 200 mg ferulic acid and 40 mg Angelica archangelica extract per daily dose, branded as Feru-guard. Ferulic acid is a phytochemical found in plant cell walls, known for **antioxidant, anti-inflammatory, and neuroprotective actions**, such as decreasing free radicals, chronic inflammation, and beta-secretase transcription, leading to reduced amyloid-beta (Aβ) aggregation and neuronal loss. Angelica archangelica root extract has been reported to inhibit acetylcholinesterase and provide antioxidative effects. This combination has shown statistically significant cognitive improvement in people with **mild cognitive impairment (MCI)** in multicenter randomized controlled trials, improving Mini-Mental State Examination (MMSE) and ADAS-Jcog scores at several weeks of supplementation. The developer and manufacturer is Glovia. No serious adverse events have been reported in large populations. Mechanistically, ferulic acid destabilizes Aβ fibrils and inhibits aggregation, while Angelica offers acetylcholinesterase inhibition, antioxidant, and anti-inflammatory actions[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferulic acid + angelica archangelica extract.